Trial intelligence / Profile preview

Infiltration of white-spot lesions during multibracket appliance treatment

DRKS00027344Phase 3Active, not recruiting

Sponsor
Charité – Universitätsmedizin Berlin
Start
Aug 2022
Modality
Small Molecules, Inorganic Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3 trial of fluoride in carious lesion and enamel subsurface lesion (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Started Aug 2022; status: active, not recruiting.

02

Drugs

fluoride
03

Conditions

carious lesionenamel subsurface lesion

Beyond the preview

Go deeper on DRKS00027344.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00027344.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call